During the past decade, HIV-NAT, Thai Red Cross AIDS Research Centre conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 12 clinical trials were completed, i.e. on average, 27.9% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 6 clinical trials were completed. i.e. 35.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HIV-NAT, Thai Red Cross AIDS Research Centre" #1 sponsor was "The HIV Netherlands Australia Thailand Research Collaboration" with 22 trials, followed by "Thai Red Cross AIDS Research Centre" with 20 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 11 trials sponsored, "South East Asia Research Collaboration with Hawaii" with 7 trials sponsored and "AIDS Clinical Trials Group" with 7 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HIV-NAT, Thai Red Cross AIDS Research Centre" #1 collaborator was "Bamrasnaradura Infectious Diseases Institute" with 8 trials as a collaborator, "Chulalongkorn University" with 8 trials as a collaborator, "Gilead Sciences" with 7 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 6 trials as a collaborator and "Kirby Institute" with 5 trials as a collaborator. Other collaborators include 131 different institutions and companies that were collaborators in the rest 95 trials.

According to Clinical.Site data, the most researched conditions in "HIV-NAT, Thai Red Cross AIDS Research Centre" are "HIV Infections" (30 trials), "HIV" (10 trials), "HIV Infection" (8 trials), "Tuberculosis" (6 trials) and "Acute HIV Infection" (4 trials). Many other conditions were trialed in "HIV-NAT, Thai Red Cross AIDS Research Centre" in a lesser frequency.

Most popular intervention types in "HIV-NAT, Thai Red Cross AIDS Research Centre" are "Drug" (44 trials), "Other" (11 trials), "Biological" (8 trials), "Dietary Supplement" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Isoniazid (INH)" (3 trials), "ATV/r" (2 trials), "Atazanavir" (2 trials) and "Darunavir" (2 trials). Other intervention names were less common.

The vast majority of trials in "HIV-NAT, Thai Red Cross AIDS Research Centre" are 67 trials for "All" genders, 11 trials for "Male" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "HIV-NAT, Thai Red Cross AIDS Research Centre". undefined are not yet recruiting, 15 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 52 completed trials in HIV-NAT, Thai Red Cross AIDS Research Centre, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in HIV-NAT, Thai Red Cross AIDS Research Centre, 6 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 10 trials that are defined as “Not Applicable".